Global Infectious Disease In Vitro Diagnostics Market Size study & Forecast, by Product (Instruments, Reagents, Software), by Application (Respiratory Virus, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, HIV, Hepatitis, COVID-19, Others), by

Global Infectious Disease In Vitro Diagnostics Market Size study & Forecast, by Product (Instruments, Reagents, Software), by Application (Respiratory Virus, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, HIV, Hepatitis, COVID-19, Others), by Technology (Immunoassay, Molecular Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029

Global Infectious Disease In Vitro Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Infectious Disease In vitro diagnostic (IVD) is a type of test that is performed on samples taken from the human body, such as blood taken from a vein or fingerstick or swabs of mucus from inside the nose or back of the throat. Infectious Disease In vitro diagnostic is used to diagnose various infectious diseases that are present in an individual’s body. The increasing geriatric population, rising incidences of target infections, coupled with the growing awareness about early diagnosis are the primary factors that are burgeoning the market demand across the globe.

As per the World Health Organization (WHO), the global geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Accordingly, the increasing geriatric population is more prone to get affected by a wide range of infectious diseases due to low immunity, which is accelerating the growth of the Infectious Disease In Vitro Diagnostics Market globally. In addition, growing demand for PoC facilities, as well as increasing funding for R&D activities are creating various lucrative opportunities for market growth over the forecasting years. However, the high cost of IVD tests stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Infectious Disease In Vitro Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the rising emphasis on disease surveillance by conducting various tests and early diagnostics, geographic expansion of key players, along with the presence of favorable regulatory framework across the region. Whereas, Asia Pacific is expected to grow significantly during the forecast period. Factors such as increasing population, rising prevalence of target diseases and infections, and rising healthcare expenditure are bolstering regional market growth in the forthcoming years.

Major market players included in this report are:
QIAGEN
bioMérieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.

Recent Developments in the Market:

In January 2020, Quest Diagnostics entered into a collaborative agreement with Memorial Hermann Health System to offer enhanced, high-quality, cost-efficient, and innovative diagnostic services for 21 hospital laboratories across the Huston region. The objective of this initiative is geographical expansion.

In June 2022, Eurobio Scientific declared the introduction of two novel tests for SARS-CoV-2 (for variants Omicron BA.2, BA.1, and BA.4/BA.5) and Monkeypox in France.
Global Infectious Disease In Vitro Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage
Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered
Product, Application, Technology, Region
Regional Scope
North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope
Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below.
By Product:
Instruments
Reagents
Software
By Application:
Respiratory Virus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatiti.
COVID-19
Others
By Technology:
Immunoassay
Molecular Diagnostics
Others
Microbiology

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australi.
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

QIAGEN
bioMérieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.